Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Pneumothorax-II01:27

Pneumothorax-II

1.2K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.2K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

1.8K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

511
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
511
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

686
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
686

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Ballistic concepts and management of gunshot wounds at members].

Revue medicale de Bruxelles·2018
Same author

Skull biomechanics: The energy absorbability of the human skull frontal bone during fracture under quasi-static loading.

Journal of applied biomaterials & biomechanics : JABB·2010
Same author

The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.

Current oncology (Toronto, Ont.)·2010
Same author

Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.

British journal of cancer·2010
Same author

Oesophageal perforation after anterior cervical surgery: management in four patients.

Acta neurochirurgica·2009
Same author

Lateral safety limits during a facial transclival approach to the craniovertebral junction.

Acta chirurgica Belgica·2009

Related Experiment Video

Updated: Mar 1, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.0K

Bleomycin-induced lung toxicity and pentoxifylline

J Goffin, H Kreisman, V Sandor

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |February 24, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
    02:46

    A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

    Published on: January 20, 2023

    5.0K
    Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
    06:52

    Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

    Published on: April 30, 2019

    18.7K

    Related Experiment Videos

    Last Updated: Mar 1, 2026

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
    06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    2.0K
    A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
    02:46

    A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

    Published on: January 20, 2023

    5.0K
    Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
    06:52

    Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

    Published on: April 30, 2019

    18.7K